商品分類

瀏覽歷史

B20261	丹酚酸B
源葉	分析標(biāo)準(zhǔn)品,HPLC≥98%

英文名：
Salvianolic acid B

別名：
丹參酚酸B;Salvianolic; 4-[2-[1-carboxy-2-(3,4-dihydroxy-phenyl)-ethoxycarbonyl]-vinyl]2-(3,4-dihydroxy-phenyl)-7-hydroxy-2,3-dihydro-benzofuran-3-carboxylic acid 1-carboxy-(3,4-dihydroxy-phenyl)-ethyl est

CAS號(hào)：
115939-25-8

分子式：
C₃₆H₃₀O₁₆

分子量：
718.62

品牌	貨號(hào)	產(chǎn)品規(guī)格	價(jià)格(RMB)	庫(kù)存（上海）	北京	武漢	南京	計(jì)量單位	加入購(gòu)物車...
源葉	B20261-5mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥150.00元	>10	-	-	-	EA	加入購(gòu)物車
源葉	B20261-20mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥400.00元	>10	6	4	10	EA	加入購(gòu)物車
源葉	B20261-100mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥1400.00元	>10	-	-	-	EA	加入購(gòu)物車
源葉	B20261-500mg	分析標(biāo)準(zhǔn)品,HPLC≥98%	￥3600.00元	>10	-	-	-	EA	加入購(gòu)物車

大包裝詢價(jià)

提交您的電話號(hào)碼并同意《個(gè)人信息授權(quán)與保護(hù)申明》，到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻(xiàn)(101篇)

質(zhì)檢證書(shū)(COA)

摩爾濃度計(jì)算器

相關(guān)產(chǎn)品

熔點(diǎn)： >250 °C

沸點(diǎn)： 1020.3°C at 760 mmHg

外觀：黃色粉末

溶解性： DMSO：15mg/ml

敏感性：易吸潮

儲(chǔ)存條件： -20℃，充氮保存

注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。

101. [3.7] Mingxin Guo et al."Pharmacological Components and Mechanism Research on the Treatment of Myelosuppression after Chemotherapy with Danggui Jixueteng Decoction Based on Spectrum-Effect Relationships and Transcriptome Sequencing."ACS Omega.2024;9(26):28926–2

100. [6.2] Ying Ren et al."Effect of CeO2, TiO2 and SiO2 nanoparticles on the growth and quality of model medicinal plant Salvia miltiorrhiza by acting on soil microenvironment."ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY.2024 Jul;280:116552

99. [4.8] Qingquan Li et al."Identification of Senkyunolide I as a novel modulator of hepatic steatosis and PPARα signaling in zebrafish and hamster models."JOURNAL OF ETHNOPHARMACOLOGY.2025 Jan;336:118743

98. [4.8] Yan Chen et al."Targeting RhoA Expression with Formononetin and Salvianolic acid B to Mitigate Pancreatic Cancer-Associated Endothelial Cells Changes."JOURNAL OF ETHNOPHARMACOLOGY.2024 Aug;:118711

97. [6.7] Ziyuan Zhao et al."Pretreatment with Dan-Shen-Yin granules alleviates ethanol-induced gastric mucosal damage in rats by inhibiting oxidative stress and apoptosis via Akt/Nrf2 signaling pathway."PHYTOMEDICINE.2024 Jul;:155866

96. [IF=2.6] Fan Yang et al."Preliminary Exploration of Potential Active Ingredients and Molecular Mechanisms of Yanggan Yishui Granules for Treating Hypertensive Nephropathy Using UPLC-Q-TOF/MS Coupled with Network Pharmacology and Molecular Docking Strategy."Journal

95. [IF=5.6] Tong Qingheng et al."Integrated chemical characterization, metabolite profiling, and pharmacokinetics analysis of Zhijun Tangshen Decoction by UPLC-Q/TOF-MS."Frontiers in Pharmacology".2024 Mar;15:

94. [IF=9.8] Ying Ren et al."Response of antioxidant activity, active constituent and rhizosphere microorganisms of Salvia miltiorrhiza to combined application of microbial inoculant, microalgae and biochar under Cu stress."SCIENCE OF THE TOTAL ENVIRONMENT".2024 May;9

93. [IF=1.1] Ji-Yong FU et al."Simultaneous determination of 19 constituents in the Jian-Nao-Ning mixture using high-performance liquid chromatography-tandem mass spectrometry."Separation Science Plus".2024 Feb;:2300222

92. [IF=4.6] Jian Zhang et al."Screening of Acetylcholinesterase Inhibitors by Capillary Electrophoresis with Oriented-Immobilized Enzyme Microreactors Based on Gold Nanoparticles."MOLECULES.2024 Jan;29(1):118

91. [IF=5.6] Shiyuan Jiang et al."Triptolide attenuates CCL4-induced liver fibrosis by regulating the differentiation of CD4+ T cells in mice."INTERNATIONAL IMMUNOPHARMACOLOGY.2023 Dec;125:111206

90. [IF=5.4] Yingqiu Shi et al."Effective constituents and protective effect of Mudan granules against Schwann cell injury."JOURNAL OF ETHNOPHARMACOLOGY.2024 Apr;323:117692

89. [IF=1.6] Nie Lanlan et al."Inhibitory effects and mechanisms of low-temperature plasma on hypertrophic scar."AIP Advances.2023 Dec;13(12):

88. [IF=2.8] Minli Yan et al."The potential effect of salvianolic acid B against rat ischemic brain injury in combination with mesenchymal stem cells."JOURNAL OF CHEMICAL NEUROANATOMY.10.1016/j.jchemneu.2023.102338

87. [6.449] Chaogeng Lyu et al."A field trials-based study reveals the effects of chlormequat chloride on the quality of medicinal plant Salvia miltiorrhiza Bge. (Lamiaceae) in practical cultivation."INDUSTRIAL CROPS AND PRODUCTS.2023 Apr;194:116396

86. [IF=3.246] Guo-Ping Wang et al."To Analyze the Mechanism of SalB Regulating SIRT1 to Inhibit NLRP3 and Its Ameliorative Effect on Tubulogastric Junction Tumor Lesions Complicated with Myocardial Injury."Biomed Research International.2022 Oct 14;2022:6560693

85. [IF=2.755] Li Qingju et al."Salvianolic Acid B Alleviates Myocardial Ischemia Injury by Suppressing NLRP3 Inflammasome Activation via SIRT1-AMPK-PGC-1α Signaling Pathway."Cardiovascular Toxicology.2022 Jul;:1-16

84. [IF=2.464] Zhou Huifen et al."Pharmacokinetic-Pharmacodynamic Modeling of Active Components from Salvia miltiorrhiza (Danshen) and Carthamus tinctorius (Honghua) in Focal Cerebral Ischemia Rats."Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy.

83. [IF=3.935] Yaqing Guo et al."An integrated strategy for the systematic chemical characterization of Salvianolate lyophilized injection using four scan modes based on the ultra-high performance liquid chromatography-triple quadrupole-linear ion trap mass spectrometry.

82. [IF=6.598] Peng Lu et al."Salvianolic acid B dry powder inhaler for the treatment of idiopathic pulmonary fibrosis."Asian Journal of Pharmaceutical Sciences. 2022 Apr;:

81. [IF=11.614] Yanqiu Gu et al."In situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography."Acta Pharmaceutica Sinica B. 2022 Apr;:

80. [IF=9.078] Jun Qian et al."A strategy for effective recovery of salvianolic acid a from Salvia miltiorrhiza (Danshen) through multiple interactions."Compos Part B-Eng. 2022 Feb;231:109563

79. [IF=5.875] Yutong Wang et al."Extra virgin olive oil-based phospholipid complex/self-microemulsion enhances oral absorption of salvianolic acid B through inhibition of catechol-O-methyltransferase-mediated metabolism."Int J Pharmaceut. 2022 Jan;611:121330

78. [IF=7.848] Mingyue Zhou et al."Oriented Layered Graphene Oxide Pad Favoring High Loading Capacity and Stability for High-Throughput Chemical Screening."Advanced Materials Technologies. 2022 Mar 11

77. [IF=1.885] Cao Weiyi et al."Simultaneous Quantification of Aspirin, Its Metabolite Salicylic Acid, and Salvianolic Acid B in Human Plasma Using UPLC-MS/MS."Int J Anal Chem. 2021;2021:6620868

76. [IF=2.1] Yang Hu et al."Salvianolic acid B alleviates myocardial ischemic injury by promoting mitophagy and inhibiting activation of the NLRP3 inflammasome."Mol Med Rep. 2020 Dec;22(6):5199-5208

75. [IF=3.411] Liu Hongyan et al."Effect Study of Continuous Monoculture on the Quality of Salvia miltiorrhiza Bge Roots."Biomed Res Int. 2020;2020:4284385

74. [IF=3.765] Shun Liu et al."Simultaneous determination of seven effective components in Shenkui Tongmai granules based on UHPLC-MS/MS."J Pharm Pharmacol. 2021 Apr;73(6):758-766

73. [IF=4.074] Jia Li et al."Omics and Transgenic Analyses Reveal that Salvianolic Acid B Exhibits its Anti-Inflammatory Effects through Inhibiting the Mincle-Syk-Related Pathway in Macrophages."J Proteome Res. 2021;XXXX(XXX):XXX-XXX

72. [IF=4.162] Weixin Hou et al."The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats."Drug Des Dev Ther. 2021; 15: 3845–3862

71. [IF=4.36] Jing Chen et al."Salvianolic acid B and ferulic acid synergistically promote angiogenesis in HUVECs and zebrafish via regulating VEGF signaling."J Ethnopharmacol. 2021 Sep;:114667

70. [IF=4.432] Dong Wang et al."Salvianolic acid B attenuates oxidative stress-induced injuries in enterocytes by activating Akt/GSK3β signaling and preserving mitochondrial function."Eur J Pharmacol. 2021 Oct;909:174408

69. [IF=4.759] Junjie Feng et al."An integrated data filtering and identification strategy for rapid profiling of chemical constituents, with Arnebiae Radix as an example."J Chromatogr A. 2020 Oct;1629:461496

68. [IF=4.759] Yi Zhang et al."Screening of inhibitors against histone demethylation jumonji domain-containing protein 3 by capillary electrophoresis."J Chromatogr A. 2020 Feb;1613:460625

67. [IF=4.759] Lu-lu Xu et al."Rapid quantitation and identification of the chemical constituents in Danhong Injection by liquid chromatography coupled with orbitrap mass spectrometry."J Chromatogr A. 2019 Nov;1606:460378

66. [IF=5.753] Yaping Xiang et al."Integrative Omics Analyses Reveal the Effects of Copper Ions on Salvianolic Acid Biosynthesis."Front Plant Sci. 2021; 12: 746117

65. [IF=5.81] Jun Li et al."Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish."Front Pharmacol. 2020; 11: 622787

64. [IF=6.529] Weiyi Cao et al."Drug-drug interactions between salvianolate injection and aspirin based on their metabolic enzymes."Biomed Pharmacother. 2021 Mar;135:111203

63. [IF=2.943] Zheng Chunli et al."System-level multi-target drug discovery from natural products with applications to cardiovascular diseases."Mol Divers. 2014 Aug;18(3):621-635

62. [IF=3.049] Jixia Wang et al."Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay."Rsc Adv. 2015 Mar;5(33):25768-25776

61. [IF=3.205] Xianhua Zhang et al."Pharmacokinetic study of representative anti-oxidative compounds from Denshen-Chuanxiong-Honghua following oral administration in rats."J Chromatogr B. 2017 May;1052:82

60. [IF=3.845] Zhang Xianhua et al."Danshen-Chuanxiong-Honghua Ameliorates Cerebral Impairment and Improves Spatial Cognitive Deficits after Transient Focal Ischemia and Identification of Active Compounds."Front Pharmacol. 2017 Jul;0:452

59. [IF=3.845] Zhang Xianhua et al."Danshen-Chuanxiong-Honghua Ameliorates Cerebral Impairment and Improves Spatial Cognitive Deficits after Transient Focal Ischemia and Identification of Active Compounds."Front Pharmacol. 2017 Jul;0:452

58. Wang, Jixia, et al. "Discovery of new targets of phenolic acids in danshen using a label-free cell phenotypic assay." RSC Advances 5.33 (2015): 25768-25776.https://doi.org/10.1039/C4RA16102E

57. Zhang, Xianhua, et al. "Danshen-Chuanxiong-Honghua ameliorates cerebral impairment and improves spatial cognitive deficits after transient focal ischemia and identification of active compounds." Frontiers in pharmacology 8 (2017): 452.

56. Zhang, Xianhua, et al. "Danshen-Chuanxiong-Honghua ameliorates cerebral impairment and improves spatial cognitive deficits after transient focal ischemia and identification of active compounds." Frontiers in pharmacology 8 (2017): 452.

55. Hu, Y., Wang, X., Li, Q., Pan, Y., Xu, L."Salvianolic acid B alleviates myocardial ischemic injury by promoting mitophagy and inhibiting activation of the NLRP3 inflammasome". Molecular Medicine Reports 22.6 (2020): 5199-5208.https://doi.org/10.3892/mmr.20

54. Li J, Liu H, Yang Z, Yu Q, Zhao L, Wang Y. Synergistic Effects of Cryptotanshinone and Senkyunolide I in Guanxinning Tablet Against Endogenous Thrombus Formation in Zebrafish. Front Pharmacol. 2021;11:622787. Published 2021 Jan 14. doi:10.3389/fphar.2020.6

53. Cao, Weiyi, et al. "Simultaneous Quantification of Aspirin, Its Metabolite Salicylic Acid, and Salvianolic Acid B in Human Plasma Using UPLC-MS/MS." International Journal of Analytical Chemistry 2021 (2021).

52. 樂(lè)世俊,王文曉,高歡,任繼國(guó),付瑞嘉,李佳佳,陳艷琰,唐于平.HPLC同時(shí)測(cè)定不同廠家丹七片中多個(gè)有效成分的含量[J].藥物分析雜志,2020,40(12):2236-2243.

51. 高瑞琳,楊鵬碩,許剛,武曉文,楊暢,史新元.基于系統(tǒng)建模思想的腦心通膠囊中丹酚酸B近紅外定量建模[J].光譜學(xué)與光譜分析,2020,40(11):3573-3578.

50. 王立,李沐謠,孫斯桐,張文君,呂江唯,崔聞?dòng)?基于滲透壓原理的丹酚酸B控釋膠囊的制備及釋放機(jī)制研究[J].中南藥學(xué),2021,19(02):198-202.

49. 葉淑青,伍清萍,鄭雨君,許啟龍,鄒雨岑,李存玉,董政起.基于臨界分離效應(yīng)的復(fù)雜溶液環(huán)境中丹酚酸B、苦參堿納濾分離規(guī)律[J].中成藥,2021,43(02):314-320.

48. 何珊,付先軍,張玲,彭霄,王振國(guó).響應(yīng)面法優(yōu)化丹參有效成分的提取工藝及其體外抗氧化活性研究[J].中華中醫(yī)藥學(xué)刊,2021,39(01):28-32+266-267.

47. 李建成,馮斌.丹酚酸B對(duì)金黃色葡萄球菌肺炎幼年小鼠肺組織修復(fù)及腦神經(jīng)保護(hù)作用的觀察[J].鄭州大學(xué)學(xué)報(bào)(醫(yī)學(xué)版),2021,56(01):102-108.

46. 崔偉亮. 丹參酒炙前后HPLC指紋圖譜色譜峰歸屬比較[J]. 遼寧中醫(yī)雜志, v.46;No.507(08):1707-1709.

45. 鄭文華, 奚亞亞, 曲叢叢,等. 酒丹參標(biāo)準(zhǔn)湯劑的質(zhì)量評(píng)價(jià). 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志.

44. 黃趙剛, 程鋼, 湯浩,等. 血必凈注射液指紋圖譜研究[J]. 中國(guó)醫(yī)院藥學(xué)雜志, 2018, 038(022):2323-2327.

43. 王蕓, 陳軍峰, 張磊,等. 基于"有效成分-性狀"的關(guān)聯(lián)分析評(píng)價(jià)丹參品質(zhì)的研究[J]. 世界科學(xué)技術(shù):中醫(yī)藥現(xiàn)代化, 2019(5):835-843.

42. 彭九嫚, 柴堯, 潘旻,等. 丹參中酚酸類成分在不同工藝條件下轉(zhuǎn)化關(guān)系[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2016, 022(005):67-70.

41. 趙志國(guó), 段文娟, 張曉夢(mèng),等. HPLC-DAD-ESI-TOF/MS鑒別和測(cè)定前列欣膠囊中多種成分及其多指標(biāo)定量指紋圖譜研究[J]. 藥物分析雜志, 2017, 037(010):1810-1816.

40. 王闖, 劉廷岳. 離子交換纖維靜態(tài)吸附丹酚酸B的熱力學(xué)研究[J]. 北京化工大學(xué)學(xué)報(bào)(自然科學(xué)版), 2012(06):17-22.

39. 夏天一, 束暢, 孫渺,等. 益氣醒腦飲的質(zhì)量標(biāo)準(zhǔn)改進(jìn)[J]. 中國(guó)醫(yī)院藥學(xué)雜志, 2017, 037(023):2364-2367.

38. 柳云,任紅旗,王增慧,楊陽(yáng),戴德淑,劉翔,胡雪晴,李向陽(yáng),劉瀛,湯仁仙.甘西鼠尾草總酚酸提取物對(duì)嘌呤霉素氨基核苷誘導(dǎo)損傷的足細(xì)胞中Toll樣受體4表達(dá)的影響[J].中國(guó)中西醫(yī)結(jié)合腎病雜志,2017,18(08):672-675.

37. 吳妍, 耿魁魁, 史天陸,等. 注射用丹參多酚酸鹽成品輸液的穩(wěn)定性[J]. 安徽醫(yī)藥, 2018, 22(6):1203-1206.

36. 黃娟, 丘小惠, 白俊其,等. 根莖類藥材丹參精準(zhǔn)煮散飲片的質(zhì)量評(píng)價(jià)[J]. 中國(guó)實(shí)驗(yàn)方劑學(xué)雜志, 2017, 023(011):18-22.

35. 吳妍, 耿魁魁, 鄧曉媚,等. 改進(jìn)HPLC法測(cè)定注射用丹參多酚酸鹽中丹酚酸B的含量[J]. 中國(guó)藥房, 2016(36).

34. 李翠, 尉廣飛, 李佳,等. 性狀異常丹參的利用價(jià)值研究[J]. 山東科學(xué), 2014, 27(002):39-43.

33. 易麗娟, 李雅, 柳蘭,等. 心痛泰顆粒HPLC指紋圖譜研究[J]. 中草藥, 2019, v.50;No.657(22):95-100.

32. 李正, 潘萬(wàn)芳, 朱立明,等. 基于物質(zhì)流分析的丹紅注射液制藥過(guò)程質(zhì)量控制研究[J]. 天津中醫(yī)藥大學(xué)學(xué)報(bào), 2015, 34(06):349-352.

31. 易麗娟, 李雅, 鄒蘇蘭,等. 基于正交試驗(yàn)設(shè)計(jì)與BP神經(jīng)網(wǎng)絡(luò)優(yōu)化益氣活血方水提工藝研究[J]. 中草藥, 2019, v.50;No.653(18):50-57.

30. 石功德, 周靜, 李敏,等. 基于R語(yǔ)言的益氣活血方藥中丹酚酸B提取工藝研究[J]. 中國(guó)中醫(yī)急癥, 2017(10):13-15+19.

29. 王藝璇李海濤劉順等. 參葵通脈顆粒的質(zhì)量標(biāo)準(zhǔn)研究[J]. 中藥新藥與臨床藥理 2020年31卷8期 984-989頁(yè) ISTIC PKU CSCD CA 2020.

28. 白一丹喬洲薛敬偉等. 參松養(yǎng)心膠囊多組分同時(shí)測(cè)定及方法學(xué)驗(yàn)證[J]. 藥物分析雜志 2018 v.38(08):80-90.

27. 李清清張繼芬. 冠心寧中14種成分的含量測(cè)定[J]. 蘇鹽科技 2019 046(006):33-35.

26. 杜秋譚寧陸洋等. 丹酚酸B液晶納米粒在體鼻吸收及體外血腦屏障細(xì)胞吸收研究[J]. 中華中醫(yī)藥雜志 2017 032(007):3140-3143.

25. 郭鄂平楊樹(shù)國(guó) 張珍等. 丹酚酸B抗小鼠日本血吸蟲(chóng)病肝纖維化的實(shí)驗(yàn)研究[J]. 現(xiàn)代預(yù)防醫(yī)學(xué) 2014 41(19):3562-3565.

24. 陳曾鳳羅濤.丹酚酸B抑制TLR2/NF-κB改善大鼠類風(fēng)濕性關(guān)節(jié)炎的作用研究[J].河北醫(yī)藥 2019 41(05):765-767.

23. 朱元美尹步金張旭等. 丹酚酸B對(duì)高糖誘導(dǎo)的腎小球系膜細(xì)胞表型轉(zhuǎn)化及細(xì)胞外基質(zhì)分泌的影響[J]. 中國(guó)病理生理雜志 2019 35(02):248-252.

22. 郭鄂平楊樹(shù)國(guó) 張珍等. 丹酚酸B對(duì)小鼠日本血吸蟲(chóng)病肝纖維化MMP-1 TIMP-1的影響[J]. 陜西醫(yī)學(xué)雜志 2014 000(003):259-261.

21. 杜秋杜守穎李鵬躍等. 丹酚酸B大鼠在體鼻循環(huán)吸收研究[J]. 中國(guó)中藥雜志 2016 41(002):303-308.

20. 劉培付君秋邵鐵梅焦展李雪仵陶安勝軍.丹酚酸B和丹參酮ⅡA對(duì)大鼠胸主動(dòng)脈外膜成纖維細(xì)胞增殖的影響[J].中國(guó)藥理學(xué)通報(bào) 2017 33(07):991-996.

19. 楊春梅曹唯儀侯俊玲等. 丹酚酸B、芍藥苷和甘草酸復(fù)配在大鼠體內(nèi)的藥動(dòng)學(xué)參數(shù)研究[J]. 西北藥學(xué)雜志 2018 33(03):94-99.

18. 周惠芬何昱艾進(jìn)超等. 丹紅注射液主要有效成分配伍在腦缺血再灌注大鼠體內(nèi)的藥動(dòng)學(xué)研究[J]. 中草藥 2016(20).

17. 艾進(jìn)超何昱楊榮兵等. 丹紅注射液中主要有效成分在腦缺血大鼠體內(nèi)藥動(dòng)學(xué)研究[J]. 中草藥 2015 46(20):79-84.

16. 時(shí)潔耿曉康 SHI 等. 丹參酚酸B對(duì)慢性腎炎大鼠的療效及作用機(jī)制研究[J]. 解放軍醫(yī)藥雜志 2017 10(v.33;No.218):11-15.

15. 尉廣飛李佳劉謙等. 丹參根部顏色及其與活性成分含量的相關(guān)性研究[J]. 山東農(nóng)業(yè)科學(xué) 2015(08):59-62.

14. 尉廣飛李翠劉謙等. 丹參根部直徑與其活性成分含有量間的相關(guān)性研究[J]. 中成藥 2015 37(008):1780-1784.

13. 尉廣飛劉謙李佳等. 丹參根部活性成分分布規(guī)律研究[J]. 山東科學(xué) 2015 28(05):7-13.

12. 何銀舟胡正明潘旻嵇晶程建明.丹參總酚酸滴丸的制備及質(zhì)量評(píng)價(jià)[J].中成藥 2019 41(10):2319-2323.

11. 宋基正李凌軍孫鵬等. 丹參總酚酸雙向調(diào)節(jié)酪氨酸酶機(jī)制及大孔樹(shù)脂分離丹酚酸B研究[J]. 中南藥學(xué) 2016(4):402-406.

10. 王國(guó)軍張琳成陳冰張宇燕孔俐韓進(jìn).丹參中丹酚酸B對(duì)腦缺血再灌注損傷大鼠的保護(hù)作用研究[J].中華中醫(yī)藥學(xué)刊 2019 37(07):1566-1568.

9. 梁從蓮張永清李佳等. 不同株系丹參有效成分比較研究[J]. 山東科學(xué) 2018(4):31-38.

8. 馮思念王瑞顧雯等. 不同強(qiáng)度的紅藍(lán)光質(zhì)對(duì)丹參根系形態(tài)和有效成分積累的影響[J]. 中草藥 2019(21).

7. 石蔚華趙筱萍陳曉玲.三葉糖脂清DPP-4抑制成分篩選及其調(diào)控JNK/AKT信號(hào)通路改善胰島素抵抗的機(jī)制研究[J].浙江中醫(yī)藥大學(xué)學(xué)報(bào) 2019 43(01):7-13.

6. 閆妍石磊史寧郭宏舉耿帥溫彬宇.UPLC-Q-TOF-MS同時(shí)測(cè)定天王補(bǔ)心片中丹參的主要成分[J].解放軍藥學(xué)學(xué)報(bào) 2018 34(01):55-57.

5. 楊春梅曹唯儀林珈好等. SPG復(fù)方主要成分配伍給藥在大鼠體內(nèi)藥動(dòng)學(xué)參數(shù)研究[J]. 遼寧中醫(yī)藥大學(xué)學(xué)報(bào) 2018 020(010):32-35.

4. 敏敏趙志國(guó) 劉偉等. HPLC-DAD法同時(shí)測(cè)定三種來(lái)源丹參飲片中水溶性和脂溶性成分[J]. 山東科學(xué) 2019(6).

3. 黃翔何昱楊潔紅等. HPLC-DAD法與UV-VIS法對(duì)丹紅注射液有效成分和有效部位的質(zhì)量控制研究[J]. 中華中醫(yī)藥雜志 2013 028(004):1066-1070.

2. 柳蘭李雅郭志華易麗娟鄒蘇蘭郭紫妍.Box-Behnken響應(yīng)面法結(jié)合G1-熵權(quán)法的理氣活血復(fù)方浸膏噴霧干燥工藝研究[J].中草藥 2019 50(11):2560-2566.

1. 牛敏劉紅燕劉謙等. 4個(gè)栽培年限丹參顏色與9種活性成分含量的相關(guān)性[J]. 中成藥 2017(1):131-135.